Published: Dec 23, 2021
Federal regulators Wednesday authorized the first easy-to-take pill to treat covid-19, a drug developed by Pfizer that will help refill the nations medicine cabinet even as the omicron variant, now dominant in much of the country, has thwarted most other options.
Published: Dec 01, 2021
Expert advisers to the Food and Drug Administration on Tuesday recommended authorization of the first coronavirus pill to prevent high-risk people from developing severe illness in a divided vote that reflects the complicated mix of benefits and risks of a new and easy mode of treatment.
Published: Nov 01, 2021
The Food and Drug Administration is delaying a decision on whether to make Modernas coronavirus vaccine available to adolescents because the agency needs more time to evaluate if the shot increases the risk of a rare cardiac side effect, the company said Sunday.
Published: Oct 27, 2021
WASHINGTON - More than 10 months after U.S. adults started receiving coronavirus vaccines, the nations younger children moved significantly closer to getting a shot of protection when advisers to the Food and Drug Administration on Tuesday endorsed the Pfizer-BioNTech vaccine.
Published: Oct 15, 2021
WASHINGTON - An independent advisory panel to the Food and Drug Administration on Thursday unanimously recommended a booster dose of the Moderna coronavirus vaccine for people 65 and older and for adults who are at high risk of severe illness because of underlying conditions or exposure on the job.
Published: Sep 23, 2021
WASHINGTON - The Food and Drug Administration on Wednesday authorized a Pfizer-BioNTech coronavirus booster shot for people 65 and older and adults at risk of severe illness, an effort to bolster protection for the most vulnerable Americans against the highly transmissible delta variant of the virus.
Published: Jun 08, 2021
WASHINGTON - The Food and Drug Administration on Monday approved the first Alzheimers treatment intended to slow cognitive decline, a move hailed by patients and advocates but sharply criticized by others who argued there was not sufficient evidence the drug works.